P. Macdonald

A randomized trial comparing intensive and passive education in patients with diabetes mellitus.

P. Conlin, A. Raji, Helen E Gomes, 2002, Archives of internal medicine.

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.

M. Berk, D. Mischoulon, C. Stough, 2019, Journal of affective disorders.

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial

M. Berk, D. Mischoulon, C. Stough, 2019, Psychopharmacology.

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,

M. Berk, D. Mischoulon, C. Stough, 2018, European Neuropsychopharmacology.

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Penny A. MacDonald, R. Bartha, M. Borrie, 2019, BMC Neurology.

Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial

A. Scholey, R. Teschke, C. Suo, 2015, Trials.

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study

A. Scholey, C. Stough, C. Bousman, 2019, The Australian and New Zealand journal of psychiatry.

L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial.

D. Karamacoska, J. Sarris, G. Byrne, 2019, Journal of psychiatric research.